Objective: To compare the effects of parecoxib sodium, an injectable prodrug of a cyclo-oxygenase-2-specific inhibitor, and ketorolac on platelet function and bleeding time in elderly individuals ...

One of the studies was conducted in healthy elderly men and women between the ages of 65 and 95 years, and the other in non-elderly adult men and women between the ages of 18 and 55 years.